Breakthrough Chemistry, Inc. BKTH
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.10K | -- | -- | -- | 13.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.10K | -- | -- | -- | 13.90K |
| Cost of Revenue | 17.80K | -- | -- | -- | 8.80K |
| Gross Profit | 1.30K | -- | -- | -- | 5.20K |
| SG&A Expenses | 153.30K | -- | -- | -- | 101.40K |
| Depreciation & Amortization | 44.90K | -- | -- | -- | 38.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 213.30K | -- | -- | -- | 149.10K |
| Operating Income | -193.90K | -- | -- | -- | -135.20K |
| Income Before Tax | -222.00K | -- | -- | -- | -187.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.22 | -- | -- | -- | -0.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -222.00K | -- | -- | -- | -187.50K |
| EBIT | -193.90K | -- | -- | -- | -135.20K |
| EBITDA | -149.20K | -- | -- | -- | -97.30K |
| EPS Basic | -0.02 | -- | -- | -- | -0.02 |
| Normalized Basic EPS | -0.01 | -- | -- | -- | -0.01 |
| EPS Diluted | -0.02 | -- | -- | -- | -0.02 |
| Normalized Diluted EPS | -0.01 | -- | -- | -- | -0.01 |
| Average Basic Shares Outstanding | 38.91M | -- | -- | -- | 36.17M |
| Average Diluted Shares Outstanding | 38.91M | -- | -- | -- | 36.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |